These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8761717)

  • 1. Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective.
    Benson CA
    Res Microbiol; 1996; 147(1-2):16-24. PubMed ID: 8761717
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials in Mycobacterium avium therapy: lessons to take home.
    Dautzenberg B
    Res Microbiol; 1994; 145(3):197-206. PubMed ID: 7809472
    [No Abstract]   [Full Text] [Related]  

  • 3. Solving the dilemma of antimycobacterial chemotherapy.
    Rastogi N; Falkinham JO
    Res Microbiol; 1996; 147(1-2):7-10. PubMed ID: 8761715
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of Mycobacterium avium complex infection.
    Mangura BT; Reichman LB
    Res Microbiol; 1994; 145(3):181-7. PubMed ID: 7809470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of infection due to Mycobacterium avium complex.
    Powderly WG
    Pediatr Infect Dis J; 1999 May; 18(5):468-9. PubMed ID: 10353523
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of disease progress in Mycobacterium avium-infected AIDS patients.
    Hoffner SE; Källenius G; Svenson SB
    Res Microbiol; 1992 May; 143(4):391-8. PubMed ID: 1455066
    [No Abstract]   [Full Text] [Related]  

  • 8. Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
    Lowe SH; Kroon FP; Bollemeyer JG; Stricker BH; van 't Wout JW
    Neth J Med; 1996 Jun; 48(6):211-5. PubMed ID: 8710040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity.
    Rastogi N; Barrow WW
    Res Microbiol; 1994; 145(3):167-8. PubMed ID: 7809466
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycobacterium avium-intracellulare infection in the acquired immunodeficiency syndrome.
    Scoular A; French P; Miller R
    Br J Hosp Med; 1991 Nov; 46(5):295-300. PubMed ID: 1958928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
    Heifets LB
    Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.
    Bachelez H; Ducloy G; Pinquier L; Rouveau M; Sibilla J; Dubertret L
    Br J Dermatol; 1996 Apr; 134(4):801-3. PubMed ID: 8733397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia and elevated 1,25(OH)(2)D(3) levels associated with disseminated Mycobacterium avium infection in AIDS.
    Playford EG; Bansal AS; Looke DF; Whitby M; Hogan PG
    J Infect; 2001 Feb; 42(2):157-8. PubMed ID: 11531324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the prevention and treatment of Mycobacterium avium disease.
    Horsburgh CR
    N Engl J Med; 1996 Aug; 335(6):428-30. PubMed ID: 8663875
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection.
    Hoy JF; Marriott D; Gottlieb T
    Med J Aust; 1996 May; 164(9):543-5. PubMed ID: 8649292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
    Yajko DM
    Res Microbiol; 1992 May; 143(4):411-9. PubMed ID: 1455069
    [No Abstract]   [Full Text] [Related]  

  • 17. New tuberculosis drug development. How can we do better?
    O'Brien RJ; Vernon AA
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1705-7. PubMed ID: 9620895
    [No Abstract]   [Full Text] [Related]  

  • 18. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
    Agins BD; Berman DS; Spicehandler D; el-Sadr W; Simberkoff MS; Rahal JJ
    J Infect Dis; 1989 Apr; 159(4):784-7. PubMed ID: 2926169
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacteria and AIDS: treatment, prevention and future prospects.
    Young LS; Bermudez LE; Inderlied CB
    Res Microbiol; 1992 May; 143(4):420-2. PubMed ID: 1455070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.